ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $752,000 | -14.4% | 60,428 | -5.8% | 0.02% | -9.5% |
| Q3 2016 | $878,000 | -20.8% | 64,167 | -57.2% | 0.02% | -8.7% |
| Q2 2016 | $1,109,000 | +435.7% | 150,016 | +362.3% | 0.02% | +283.3% |
| Q1 2016 | $207,000 | -51.9% | 32,451 | -52.8% | 0.01% | -14.3% |
| Q4 2015 | $430,000 | -36.3% | 68,753 | -40.5% | 0.01% | -36.4% |
| Q3 2015 | $675,000 | -33.0% | 115,643 | -5.0% | 0.01% | -38.9% |
| Q2 2015 | $1,007,000 | +38.7% | 121,761 | +38.1% | 0.02% | +20.0% |
| Q1 2015 | $726,000 | +109.2% | 88,150 | +37.1% | 0.02% | +114.3% |
| Q3 2014 | $347,000 | -39.2% | 64,282 | -28.4% | 0.01% | -22.2% |
| Q2 2014 | $571,000 | +175.8% | 89,733 | +250.0% | 0.01% | +200.0% |
| Q1 2014 | $207,000 | -76.2% | 25,640 | -45.7% | 0.00% | -72.7% |
| Q3 2013 | $868,000 | – | 47,204 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |